| Pharmacology and functions of metabotropic glutamate receptors PJ Conn, JP Pin Annual review of pharmacology and toxicology 37 (1), 205-237, 1997 | 3747 | 1997 |
| The metabotropic glutamate receptors: structure and functions JP Pin, R Duvoisin Neuropharmacology 34 (1), 1-26, 1995 | 2876 | 1995 |
| Molecular tinkering of G protein‐coupled receptors: an evolutionary success J Bockaert, JP Pin The EMBO journal, 1999 | 2113 | 1999 |
| Glutamate stimulates inositol phosphate formation in striatal neurones F Sladeczek, JP Pin, M Récasens, J Bockaert, S Weiss Nature 317 (6039), 717-719, 1985 | 931 | 1985 |
| Evolution, structure, and activation mechanism of family 3/C G-protein-coupled receptors JP Pin, T Galvez, L Prézeau Pharmacology & therapeutics 98 (3), 325-354, 2003 | 835 | 2003 |
| International Union of Pharmacology. XLVI. G protein-coupled receptor list SM Foord, TI Bonner, RR Neubig, EM Rosser, JP Pin, AP Davenport, ... Pharmacological reviews 57 (2), 279-288, 2005 | 798 | 2005 |
| NMDA receptors activate the arachidonic acid cascade system in striatal neurons A Dumuis, M Sebben, L Haynes, JP Pin, J Bockaert Nature 336 (6194), 68-70, 1988 | 762 | 1988 |
| The Concise Guide to PHARMACOLOGY 2019/20: G protein‐coupled receptors SPH Alexander, A Christopoulos, AP Davenport, E Kelly, A Mathie, ... British journal of pharmacology 176, S21-S141, 2019 | 742 | 2019 |
| Metabotropic glutamate receptors: from the workbench to the bedside F Nicoletti, J Bockaert, GL Collingridge, PJ Conn, F Ferraguti, ... Neuropharmacology 60 (7-8), 1017-1041, 2011 | 695 | 2011 |
| Virtual screening workflow development guided by the “receiver operating characteristic” curve approach. Application to high-throughput docking on metabotropic glutamate … N Triballeau, F Acher, I Brabet, JP Pin, HO Bertrand Journal of medicinal chemistry 48 (7), 2534-2547, 2005 | 673 | 2005 |
| G protein–coupled receptor oligomerization revisited: functional and pharmacological perspectives S Ferré, V Casadó, LA Devi, M Filizola, R Jockers, MJ Lohse, G Milligan, ... Pharmacological reviews 66 (2), 413-434, 2014 | 593 | 2014 |
| Cell-surface protein-protein interaction analysis with time-resolved FRET and snap-tag technologies: application to GPCR oligomerization D Maurel, L Comps-Agrar, C Brock, ML Rives, E Bourrier, MA Ayoub, ... Nature methods 5 (6), 561-567, 2008 | 567 | 2008 |
| Agonist-independent activation of metabotropic glutamate receptors by the intracellular protein Homer F Ango, L Prézeau, T Muller, JC Tu, B Xiao, PF Worley, JP Pin, J Bockaert, ... nature 411 (6840), 962-965, 2001 | 479 | 2001 |
| Building a new conceptual framework for receptor heteromers S Ferré, R Baler, M Bouvier, MG Caron, LA Devi, T Durroux, K Fuxe, ... Nature chemical biology 5 (3), 131-134, 2009 | 475 | 2009 |
| Allosteric interactions between GB1 and GB2 subunits are required for optimal GABAB receptor function T Galvez, B Duthey, J Kniazeff, J Blahos, G Rovelli, B Bettler, L Prézeau, ... The EMBO journal 20 (9), 2152-2159, 2001 | 461 | 2001 |
| The Concise Guide to PHARMACOLOGY 2021/22: G protein‐coupled receptors SPH Alexander, A Christopoulos, AP Davenport, E Kelly, A Mathie, ... British journal of pharmacology 178, S27-S156, 2021 | 447 | 2021 |
| Generic GPCR residue numbers–aligning topology maps while minding the gaps V Isberg, C De Graaf, A Bortolato, V Cherezov, V Katritch, FH Marshall, ... Trends in pharmacological sciences 36 (1), 22-31, 2015 | 444 | 2015 |
| Time-resolved FRET between GPCR ligands reveals oligomers in native tissues L Albizu, M Cottet, M Kralikova, S Stoev, R Seyer, I Brabet, T Roux, ... Nature chemical biology 6 (8), 587-594, 2010 | 390 | 2010 |
| CPCCOEt, a noncompetitive metabotropic glutamate receptor 1 antagonist, inhibits receptor signaling without affecting glutamate binding S Litschig, F Gasparini, D Rueegg, N Stoehr, PJ Flor, I Vranesic, ... Molecular pharmacology 55 (3), 453-461, 1999 | 388 | 1999 |
| The metabotropic glutamate receptors: structure, activation mechanism and pharmacology JP Pin, F Acher Current Drug Targets-CNS & Neurological Disorders 1 (3), 297-317, 2002 | 382 | 2002 |
